Amongst six of eight studies, APOE status did not relate to SCD measures, and in one case (Study 30) all participants were categorized as having SCD, and only the “convenience” (compared with “population”-based) sample had biomarker data, which did not allow for the comparison of SCD-plus criteria. The gene discussed is APOE; the disease is Schnyder corneal dystrophy.